ANDREW SHREVE: Open Payments
NPI 1720442460 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 51 payments from 17 companies in 2025. Trend: 2023 $1,166 · 2024 $1,459 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $266 |
| Janssen Biotech, Inc. | 6 | $245 |
| UROGEN PHARMA, INC. | 5 | $155 |
| Sumitomo Pharma America, Inc. | 6 | $111 |
| Dendreon Pharmaceuticals LLC | 1 | $49 |
| Antares Pharma, Inc. | 3 | $47 |
| Endo USA, Inc. | 2 | $43 |
| IMMUNITYBIO, INC. | 1 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $33 |
Products named: BOTOX, RYBREVANT, ERLEADA, GEMTESA, PROVENGE, XYOSTED, XIAFLEX, ANKTIVA.
Industry payments across AL — which companies pay providers there.
